These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

386 related items for PubMed ID: 7631260

  • 21. [Lung toxicity of trimodality chemoradiotherapy with mitomycin C, vindesine, and cisplatin followed by surgery for locally advanced non-small cell lung cancer].
    Sawa T, Yoshida T, Ishiguro T, Ogawara M, Kawahara M, Yamamoto S, Yokota S, Maeda H, Asamoto H.
    Gan To Kagaku Ryoho; 2003 Oct; 30(11):1745-9. PubMed ID: 14619509
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
    Valentini V, Morganti AG, Gambacorta MA, Mohiuddin M, Doglietto GB, Coco C, De Paoli A, Rossi C, Di Russo A, Valvo F, Bolzicco G, Dalla Palma M, Study Group for Therapies of Rectal Malignancies (STORM).
    Int J Radiat Oncol Biol Phys; 2006 Mar 15; 64(4):1129-39. PubMed ID: 16414206
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Induction chemotherapy with carboplatin/paclitaxel followed by surgery or standard radiotherapy and concurrent daily low-dose cisplatin for locally advanced non-small cell lung cancer (NSCLC).
    De Candis D, Stani SC, Bidoli P, Bedini VA, Potepan P, Navarria P, Aglione S, Bajetta E.
    Am J Clin Oncol; 2003 Jun 15; 26(3):265-9. PubMed ID: 12796598
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Phase II trial of postoperative adjuvant paclitaxel/carboplatin and thoracic radiotherapy in resected stage II and IIIA non-small-cell lung cancer: promising long-term results of the Radiation Therapy Oncology Group--RTOG 9705.
    Bradley JD, Paulus R, Graham MV, Ettinger DS, Johnstone DW, Pilepich MV, Machtay M, Komaki R, Atkins J, Curran WJ, Radiation Therapy Oncology Group.
    J Clin Oncol; 2005 May 20; 23(15):3480-7. PubMed ID: 15908657
    [Abstract] [Full Text] [Related]

  • 28. [Multimodal treatment of non small cell lung cancer].
    Stoelben E, Digel W, Henke M, Passlick B.
    Zentralbl Chir; 2006 Apr 20; 131(2):110-4. PubMed ID: 16612776
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. [Results of radiotherapy combined with CDDP (BAI) plus VP-16 in the treatment of inoperable non-small cell lung cancer].
    Moriyama T, Miyazono N, Mukai H, Miyaji N, Inoue H, Oyama T, Nakajo M, Tanohata S.
    Nihon Igaku Hoshasen Gakkai Zasshi; 1996 Feb 20; 56(3):116-20. PubMed ID: 8725336
    [Abstract] [Full Text] [Related]

  • 33. [Neoadjuvant therapy of stage III non-small cell lung cancer].
    Hara N, Ohta M.
    Kyobu Geka; 1991 Dec 20; 44(13):1114-20. PubMed ID: 1661792
    [Abstract] [Full Text] [Related]

  • 34. [Surgery and adjuvant therapy of non-small cell lung cancer].
    Watanabe Y, Yamada T, Ichihashi T, Hashizume Y, Iwa T.
    Gan To Kagaku Ryoho; 1986 Apr 20; 13(4 Pt 2):1534-46. PubMed ID: 3524465
    [Abstract] [Full Text] [Related]

  • 35. Phase II study of intensive chemotherapy with carboplatin, ifosfamide and etoposide plus recombinant human granulocyte colony-stimulating factor and sequential radiotherapy in locally advanced, unresectable non-small-cell lung cancer.
    Scagliotti GV, Ricardi U, Crinó L, Maranzano E, De Marinis F, Morandi MG, Meacci L, Marangolo M, Emiliani E, Rosti G, Figoli F, Bolzicco G, Masiero P, Gentile A, Tonato M.
    Cancer Chemother Pharmacol; 1996 Apr 20; 38(6):561-5. PubMed ID: 8823499
    [Abstract] [Full Text] [Related]

  • 36. [Treatment of non-small-cell bronchial carcinoma with cisplatin, ifosfamide, vindesine and VP 16].
    Drings P, Manke HG.
    Strahlentherapie; 1985 Mar 20; 161(3):131-3. PubMed ID: 2983459
    [Abstract] [Full Text] [Related]

  • 37. Treatment of modified Stage II (T1 N1 M0, T2 N1 M0) non-small cell bronchogenic carcinoma. A combined modality approach.
    Newman SB, DeMeester TR, Golomb HM, Hoffman PC, Little AG, Raghavan V.
    J Thorac Cardiovasc Surg; 1983 Aug 20; 86(2):180-5. PubMed ID: 6308356
    [Abstract] [Full Text] [Related]

  • 38. [Clinical value of postoperative chemotherapy for non-small cell lung cancer--with special reference to long-term combined chemotherapy combined with immunotherapy].
    Watanabe Y, Sato H, Iida S, Yamada T, Kobayashi H, Kimoto H, Tsunamura Y, Ichihashi T, Shimizu J, Hashizume Y.
    Gan To Kagaku Ryoho; 1985 Jan 20; 12(1):21-35. PubMed ID: 2981515
    [Abstract] [Full Text] [Related]

  • 39. [Adjuvant therapy in resectable non-small cell lung cancer].
    Hashimoto K, Sagawa M, Sato M, Nagamoto N, Usuda K, Ohta S, Kanma K, Imai T, Saito Y, Suda H.
    Gan No Rinsho; 1986 Oct 20; 32(13):1752-6. PubMed ID: 2432289
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 20.